ERBB2 and polyp: The findings illustrated that only ERBB2 mutations (n = 5) displayed a significant correlation with polyp recurrence, displaying a shorter median polyp-free interval of 15 months compared to 26 months than the wild types (n = 85) (P < 0.001; HR = 4.9; 95% CI = 1.9–12.8).